Baird Financial Group
ASND icon

Baird Financial Group’s Ascendis Pharma A/S ASND Stock Holding History

Baird Financial Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.86M Buy
+10,735
New +$2.51M ﹤0.01% 966
2021
Q3 		– Sell
-3,000
Closed -$395K – 1854
2021
Q2 		$395K Buy
+3,000
New +$400K ﹤0.01% 1486

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Baird Financial Group's ASND Position: Q2 2026 in Review

Baird Financial Group opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 10,735 shares worth $2.86M. The stake represents ﹤0.01% of the portfolio and ranks #966 among its holdings. This is a return to the name: Baird Financial Group previously reported a position in ASND as recently as Q2 2021.

Baird Financial Group first reported a position in ASND in Q2 2021 and has held it in 2 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Baird Financial Group held 10,735 shares of Ascendis Pharma A/S worth $2.86M as of Q2 2026.
  • Ascendis Pharma A/S was a new Baird Financial Group position in Q2 2026.
  • Ascendis Pharma A/S made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #966 holding.
  • Baird Financial Group first reported a position in Ascendis Pharma A/S in Q2 2021 and has held it in 2 quarters since.
  • 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.